Laboratory of Drug Metabolism and Pharmacokinetics, Shenyang Pharmaceutical University, Shenyang 110016, PR China.
Contraception. 2012 Apr;85(4):419-24. doi: 10.1016/j.contraception.2011.08.018. Epub 2011 Oct 11.
Some side effects of copper intrauterine devices (Cu-IUDs) including increased uterine bleeding, pelvic infections and pain have been reported. The presence of indomethacin in such devices was found to be effective in relieving the symptoms. The aim of this study was to develop and validate a rapid and sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) method for measuring plasma and uterine tissue levels of indomethacin in rabbits after insertion of indomethacin-medicated Cu-IUDs.
Indomethacin was extracted from rabbit plasma and uterine tissue by a simple protein precipitation using acetonitrile. Chromatographic separation was carried out on a Diamonsil C(18) column (150×4.6 mm ID, 5 μm) with an isocratic mobile phase consisting of methanol, acetonitrile, water and formic acid (45:45:10:0.5, v/v/v/v). Mass spectrometric detection was achieved by a triple-quadrupole mass spectrometer equipped with an atmospheric pressure chemical ionization interface operating in positive ionization mode. Quantitation was performed using selective reaction monitoring mode. The LC-MS/MS method was validated with respect to selectivity, linearity, precision, accuracy, extraction recovery and stability, and then applied to the in vivo studies of indomethacin in rabbits treated with indomethacin-medicated Cu-IUDs.
The linear calibration curves of indomethacin in plasma and uterine tissue were obtained over the concentration range of 2.0-400 ng/mL and 4.0-800 ng/mL, respectively. The intra- and interday precision was less than 9.5%, and the relative error was within ±5.3%. After insertion of indomethacin-medicated Cu-IUDs in rabbits, indomethacin was rapidly absorbed, and peak plasma levels were reached in approximately 1 h. A multiphasic elimination pattern was observed, which was a rapid decline in plasma concentration during the first 100 h followed by a very slow clearance phase. The uterine indomethacin levels were significantly higher than simultaneous plasma levels.
The developed method proved to be rapid and sensitive, and was successfully applied to investigate the absorption and uterine distribution of indomethacin in rabbits after insertion of indomethacin-medicated Cu-IUDs.
已报道铜宫内节育器(Cu-IUD)的一些副作用,包括增加子宫出血、盆腔感染和疼痛。在这些装置中加入吲哚美辛被发现可有效缓解症状。本研究旨在开发和验证一种快速灵敏的液相色谱-串联质谱(LC-MS/MS)法,用于测量兔插入吲哚美辛载药 Cu-IUD 后血浆和子宫组织中吲哚美辛的浓度。
用乙腈简单的蛋白沉淀法从兔血浆和子宫组织中提取吲哚美辛。色谱分离在 Diamonsil C(18)柱(150×4.6mm ID,5μm)上进行,采用甲醇、乙腈、水和甲酸(45:45:10:0.5,v/v/v/v)的等度流动相。质谱检测采用大气压化学电离接口的三重四极杆质谱仪,正离子化模式。定量采用选择反应监测模式。该 LC-MS/MS 方法经过选择性、线性、精密度、准确度、提取回收率和稳定性验证,然后应用于兔吲哚美辛载药 Cu-IUD 治疗的体内研究。
吲哚美辛在血浆和子宫组织中的线性校准曲线分别在 2.0-400ng/mL 和 4.0-800ng/mL 的浓度范围内获得。日内和日间精密度均小于 9.5%,相对误差在±5.3%以内。兔插入吲哚美辛载药 Cu-IUD 后,吲哚美辛迅速吸收,约 1h 达到血浆峰值水平。观察到多相消除模式,即在最初 100h 内血浆浓度迅速下降,随后清除速度非常缓慢。子宫内吲哚美辛水平明显高于同时的血浆水平。
所开发的方法快速灵敏,成功应用于研究兔插入吲哚美辛载药 Cu-IUD 后吲哚美辛的吸收和子宫分布。